FDA Recall Notice: Eugia U.S. Issues Voluntary Nationwide Recall of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL Due to Presence of Particulate Matter
November 10, 2026
November 10, 2026
WASHINGTON, Nov. 10 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following recall notice:
* * *
Eugia US LLC (f/k/a Auro Medics Pharma LLC) Issues Voluntary Nationwide Recall of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial) Due to Presence of Particulate Matter
Summary
Company Announcement Date: November 06, 2026
FDA Publish Date: November 09, 2026
. . .
* * *
Eugia US LLC (f/k/a Auro Medics Pharma LLC) Issues Voluntary Nationwide Recall of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial) Due to Presence of Particulate Matter
Summary
Company Announcement Date: November 06, 2026
FDA Publish Date: November 09, 2026
. . .
